The chemical substance known as "4-[(4-butylcyclohexyl)carbonyl]-7-fluoro-5-(4-fluorophenyl)-1,3,4,5-tetrahydro-2H-1,4-benzodiazepin-2-one," with the CAS number 6230-93-9, is a member of the benzodiazepine class, which is characterized by its bicyclic structure containing a benzene ring fused to a diazepine ring. This compound features several notable functional groups, including a carbonyl group and fluorine substituents, which can influence its pharmacological properties and biological activity. The presence of the butylcyclohexyl moiety may enhance lipophilicity, potentially affecting its absorption and distribution in biological systems. Benzodiazepines are often studied for their anxiolytic, sedative, and muscle relaxant properties, and modifications to their structure can lead to variations in potency and side effects. The specific arrangement of substituents in this compound suggests potential applications in medicinal chemistry, particularly in the development of new therapeutic agents targeting the central nervous system. However, detailed studies would be necessary to fully elucidate its pharmacodynamics and pharmacokinetics.

4-[(4-butylcyclohexyl)carbonyl]-7-fluoro-5-(4-fluorophenyl)-1,3,4,5-tetrahydro-2H-1,4-benzodiazepin-2-one

6230-93-9: The chemical substance known as "4-[(4-butylcyclohexyl)carbonyl]-7-fluoro-5-(4-fluorophenyl)-1,3,4,5-tetrahydro-2H-1,4-benzodiazepin-2-one," with the CAS number 6230-93-9, is a member of the benzodiazepine class, which is characterized by its bicyclic structure containing a benzene ring fused to a diazepine ring. This compound features several notable functional groups, including a carbonyl group and fluorine substituents, which can influence its pharmacological properties and biological activity. The presence of the butylcyclohexyl moiety may enhance lipophilicity, potentially affecting its absorption and distribution in biological systems. Benzodiazepines are often studied for their anxiolytic, sedative, and muscle relaxant properties, and modifications to their structure can lead to variations in potency and side effects. The specific arrangement of substituents in this compound suggests potential applications in medicinal chemistry, particularly in the development of new therapeutic agents targeting the central nervous system. However, detailed studies would be necessary to fully elucidate its pharmacodynamics and pharmacokinetics.

CAS 6230-93-9

4-[(4-butylcyclohexyl)carbonyl]-7-fluoro-5-(4-fluorophenyl)-1,3,4,5-tetrahydro-2H-1,4-benzodiazepin-2-one

4-Methoxyphenylalanine

Ref: 7W-GM6076